Home
-
Message from the Director
The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value for our academic and research community.
-
New Anti-Aging Compound Stands Up to the Sun
It is important to protect yourself from the damaging effects of the sun. But you wouldn’t go outside without sunscreen, so problem solved. Right? Not necessarily.
-
CDD Invention Sulfanegen
CDD Invention, Sulfanegen, featured as the new antidote to poisonous cyanide attacks
Center for Drug Design's Research on Popcorn Additive, Diacetyl (DA), and its relationship with Alzheimer's Disease featured in Chemical & Engineering News (C&EN)
A recently reported study out of the laboratories of Prof Robert Vince (Director, Center for Drug Design), raises concern about chronic exposure of workers in industry to a food flavoring ingredient used to produce the distinctive buttery flavor and aroma of microwave popcorn, margarines, snack foods, candy, baked goods, pet foods and other products. Evidence that the ingredient, diacetyl (DA), intensifies the damaging effects of an abnormal brain protein linked to Alzheimer’s disease has been found. The study appears in American Chemical Society's (ACS) journal, Chemical Research in Toxicology and has been featured in July 23 edition of the Chemical and Engineering News magazine of ACS.
Employment Opportunities
(I) Research Associate (Bio-analytical Chemistry and Pharmacokinetics)
The Center for Drug Design (CDD) at University of Minnesota is dedicated to designing and developing new medicines to benefit people worldwide. We are currently looking for an individual responsible for maintaining a PK core facility within the CDD to support multiple drug discovery projects focused on therapeutic areas ranging from cancer to infectious diseases. For details on the position, please Click Here.
(II) Post-doctoral Opening
One postdoctoral associate position is available at the Center for Drug Design at the University of Minnesota, Twin Cities to study small molecules as potential therapeutics for Parkinson’s disease and cancer. Click Here
